ArticleOne health (Amsterdam, Netherlands)2021
One Health approach on human seroprevalence of anti-
Article in One health (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.
- Measurement in the study of human exposure to animal feces: A systematic review and audit.International journal of hygiene and environmental health · 2023Pooled it
- Human and Canine Seropositivity toPathogens (Basel, Switzerland) · 2026Article
- Seroprevalence and Risk Factors Associated with Anti-International journal of environmental research and public health · 2026Article
- One Health approach on toxocariasis and ophthalmic assessment in owners and dogs.Scientific reports · 2026Article
- Molecular detection of hemotropic mycoplasmas (hemoplasmas) in humans and dogs living on islands and the seashore mainland of Brazil: a One Health approach.Parasites & vectors · 2026Article
- Socioeconomic vulnerability associated with toxocariasis exposure in southern Brazil: a One Health approach.Frontiers in public health · 2026Article
- High toxocariasis seroprevalence in a tri-border indigenous community (Brazil, Paraguay and Argentina): A One Health perspective.One health (Amsterdam, Netherlands) · 2025Article
- Toxocariasis as an Elderly Zoonosis: Seroprevalence, Neurocognitive Assessment, and Associated Risk Factors in Persons 50 Years and Older.Pathogens (Basel, Switzerland) · 2025Article
- Prevalence of Toxocara infection and associated risk factors: a cross-sectional study in Zhejiang, China.Infectious diseases of poverty · 2025Article
- One Health approach toFrontiers in public health · 2025Article
- Molecular Determination ofJournal of parasitology research · 2024Article
- Risk factors for toxocariasis during incarceration: the One Health intervention approach.Scientific reports · 2023Article
- Prevalence and risk factors associated with Toxocara canis in dogs and humans in Egypt: A comparative approach.Veterinary medicine and science · 2023Article
- Spatial Owner-Dog Seroprevalence ofTropical medicine and infectious disease · 2023Article
- Diversity of helminths with zoonotic potential and molecular characterization of Toxocara canis infecting domestic dogs from locations of Amazon and Atlantic Forest Brazilian biomes.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2023Article
- One health approach to toxocariasis in Brazilian indigenous populations, their dogs, and soil contamination.Frontiers in public health · 2023Article
- Serosurvey of anti-Toxocara canis antibodies in people experiencing homelessness and shelter workers from São Paulo, Brazil.Parasites & vectors · 2022Article
- Seropositivity of Anti-Tropical medicine and infectious disease · 2022Article
- Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput Serology.Pathogens (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 9 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Toxocariasis, caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.